Omicron BA.5 Subvariant Provokes the Fifth COVID-19 Wave in Mexico: Closer to the End of This Pandemic

被引:1
作者
De La Cruz-Hernandez, Sergio Isaac [1 ]
Alvarez-Contreras, Ana Karen [2 ]
机构
[1] Minist Hlth Mexico, Dept Virol, Inst Epidemiol Diag & Reference InDRE, Mexico City, Mexico
[2] Natl Polytech Inst, Natl Sch Biol Sci, Dept Microbiol, Mexico City, Mexico
关键词
COVID-19; Mexico; Omicron subvariant BA.5; SARS-CoV-2; vaccinated people; VARIANT;
D O I
10.1017/dmp.2023.14
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Optimal Control Strategy of a Mathematical Model for the Fifth Wave of COVID-19 Outbreak (Omicron) in Thailand
    Lamwong, Jiraporn
    Wongvanich, Napasool
    Tang, I-Ming
    Pongsumpun, Puntani
    Wang, Jin
    MATHEMATICS, 2024, 12 (01)
  • [22] Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
    Zeng, Ting
    Lu, Yaoqin
    Zhao, Yanji
    Guo, Zihao
    Sun, Shengzhi
    Teng, Zhidong
    Tian, Maozai
    Wang, Jun
    Li, Shulin
    Fan, Xucheng
    Wang, Weiming
    Cai, Yongli
    Liao, Gengze
    Liang, Xiao
    He, Daihai
    Wang, Kai
    Zhao, Shi
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [23] Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts
    Ting Zeng
    Yaoqin Lu
    Yanji Zhao
    Zihao Guo
    Shengzhi Sun
    Zhidong Teng
    Maozai Tian
    Jun Wang
    Shulin Li
    Xucheng Fan
    Weiming Wang
    Yongli Cai
    Gengze Liao
    Xiao Liang
    Daihai He
    Kai Wang
    Shi Zhao
    Respiratory Research, 24
  • [24] Reflections on teaching and learning during the omicron wave of the COVID-19 pandemic and economic inflation
    Khareedi, Rohini
    Ratnaweera, Priyadarshanee Manorika
    EUROPEAN JOURNAL OF DENTAL EDUCATION, 2024, 28 (01) : 114 - 116
  • [25] The Evolving Impact of Myocardial Injury in Patients With COVID-19 Amid the Omicron Wave of the Pandemic
    Case, Brian C.
    Shea, Corey
    Rappaport, Hank
    Cellamare, Matteo
    Zhang, Cheng
    Zhu, Mason
    Medranda, Giorgio A.
    Satler, Lowell F.
    Ben-Dor, Itsik
    Hashim, Hayder
    Rogers, Toby
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 190 : 54 - 60
  • [26] Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines
    Lustig, Yaniv
    Barda, Noam
    Weiss-Ottolenghi, Yael
    Indenbaum, Victoria
    Margalit, Ili
    Asraf, Keren
    Doolman, Ram
    Chalkias, Spyros
    Das, Rituparna
    Elfatarany, Gamal
    Harats, Dror
    Kreiss, Yitshak
    Regev-Yochay, Gili
    VACCINE, 2024, 42 (22)
  • [27] Phylogenetic, Sequencing, and Mutation Analysis of SARS-CoV-2 Omicron (BA.1) and Its Subvariants (BA.1.1, BA.2) During the Fifth Wave of the COVID-19 Pandemic in the Iraqi Kurdistan Region
    Taher, Sherzad M.
    Abdo, Jassim M.
    Merza, Muayad A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [28] Turning point: A new global COVID-19 wave or a signal of the beginning of the end of the global COVID-19 pandemic?
    Ding, Kaixi
    Jiang, Wei
    Xiong, Chunping
    Lei, Ming
    IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (04)
  • [29] Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States
    Di Fusco, Manuela
    Marczell, Kinga
    Thoburn, Elizabeth
    Wiemken, Timothy. L. L.
    Yang, Jingyan
    Yarnoff, Benjamin
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 509 - 524
  • [30] Effectiveness of COVID-19 booster vaccination, morbidity and absenteeism among healthcare personnel during the 2022-2023 season dominated by Omicron BA.5 and BA.2 subvariants
    Maltezou, Helena C.
    Gamaletsou, Maria N.
    Giannouchos, Theodoros, V
    Koukou, Dimitra-Maria
    Sourri, Flora
    Karapanou, Amalia
    Lemonakis, Nikolaos
    Souliotis, Kyriakos
    Lourida, Athanasia
    Panagopoulos, Periklis
    Hatzigeorgiou, Dimitrios
    Sipsas, Nikolaos, V
    VACCINE, 2024, 42 (17) : 3693 - 3698